BioCentury
ARTICLE | Company News

MediVas, Merck deal

February 5, 2007 8:00 AM UTC

The companies will apply MediVas’ polyesteramide (PEA) copolymer delivery technology to undisclosed MRK oral biologics. MRK also has an exclusive option to use the technology with additional undisclos...